Travere Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Feb2011 Feb2012 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.02M-0.01M-30.34M-34.62M-110.94M117.24M-47.90M-59.73M-102.68M-146.43M-169.43M37.20M52.99M264.93M-0.92M
Depreciation and Depletion 0.10M0.10M0.50M0.60M0.70M2.10M1.70M2.10M2.20M1.80M
Share-based Compensation 22.41M5.44M15.90M25.90M29.10M26.87M19.77M21.11M23.61M29.57M38.14M44.25M36.91M
Deferred Taxes -9.73M-2.46M-15.57M-22.66M-6.42M
Cash from Discontinued Operations 61.45M74.56M45.34M-7.45M
Gains from Investment Securities 10.10M23.79M33.31M18.38M19.39M15.00M15.05M-12.41M-16.42M-1.35M3.63M-7.94M
Asset Writedowns and Impairment 4.71M25.50M2.23M0.50M1.04M3.04M2.82M
Non-cash Items 2.46M1.98M1.72M1.36M
Cash from Operations -0.00M-0.00M-2.74M-17.59M-45.85M-1.39M-3.44M7.40M-24.96M-58.21M-42.74M-76.24M-260.85M-325.36M-237.47M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.01M0.40M1.10M-1.34M0.46M0.79M-0.70M-2.01M0.70M7.46M4.54M
Amortization of Deferred Charges 4.71M1.34M0.66M0.66M3.40M9.90M10.48M11.24M1.62M1.72M1.73M
Depreciation & Amortization (CF) 0.12M0.22M5.40M13.39M16.14M17.80M18.67M20.41M24.58M12.75M20.72M38.53M43.55M
Change in Working Capital
Change in Receivables 7.96M4.50M6.09M-4.95M-0.15M5.18M-2.30M-0.85M1.06M11.26M6.00M
Change in Inventory 0.28M1.17M0.57M1.71M2.77M1.96M5.07M-0.12M1.21M39.42M3.77M
Change in Account Payables 0.68M-2.92M2.06M-2.71M9.26M-6.04M2.77M2.31M
Change in Accured Expenses 2.98M2.84M20.60M3.38M12.59M0.60M16.17M4.60M4.42M16.68M22.18M24.76M-31.06M
Change in Taxes 8.11M-4.64M-0.62M-1.13M-0.56M15.75M-17.10M0.37M0.04M0.04M
Other Working Capital Changes 0.01M1.35M-0.24M0.97M2.45M2.70M1.36M-0.21M4.31M38.30M-12.93M-15.78M-6.12M
Investing Activities
Capital Expenditures 0.02M0.12M0.66M0.02M1.43M0.89M0.73M0.20M6.77M5.10M0.19M0.67M
Sales of Property, Plant and Equipment 148.41M
Change in Intangibles -1.17M5.43M3.30M7.01M10.50M13.12M18.97M15.37M17.80M19.05M28.37M41.59M36.21M
Acquisitions 0.00M29.15M33.43M0.61M95.28M
Divestments 207.40M
Change in Acquisitions & Divestments 4.38M6.49M10.00M159.52M114.53M162.80M259.14M273.48M433.60M381.99M334.57M326.33M
Cash from Investing Activities -1.70M-5.41M-37.26M-80.60M10.37M45.60M-203.29M19.86M-61.33M-137.62M-32.55M-151.63M99.33M
Financing Activities
Other financing activities 2.42M-0.36M0.66M1.71M1.78M-6.10M9.88M-1.38M
Cash from Financing Activities 4.44M28.98M95.32M101.60M-3.85M5.45M231.86M-2.08M127.71M237.79M120.05M220.13M139.42M
Additional items
Exchange Rate Effect -0.01M0.12M-0.06M-0.14M-0.01M-1.31M1.71M-2.79M1.98M-0.91M
Change in Cash 0.00M5.99M12.21M19.60M3.20M58.39M3.48M-40.44M22.34M80.98M-104.06M-3.51M0.36M
Beginning Cash Balance 0.03M0.01M
Free Cash Flow -0.00M-0.00M-2.76M-17.71M-46.51M-1.41M-4.87M6.52M-25.68M-58.41M-49.51M-81.34M-261.04M-326.02M-237.47M
Net Cash Flow -0.00M-0.00M0.00M5.99M12.21M19.61M3.08M58.45M3.61M-40.43M23.64M23.93M-173.35M-256.85M1.27M